Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Innovate Biopharmaceuticals (INNT) Competitors

Innovate Biopharmaceuticals logo

INNT vs. SCPS, VAXX, EVLO, CMRA, ARDS, STAB, CLVR, EFTR, MTEM, and ONCSQ

Should you be buying Innovate Biopharmaceuticals stock or one of its competitors? The main competitors of Innovate Biopharmaceuticals include Scopus BioPharma (SCPS), Vaxxinity (VAXX), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Clever Leaves (CLVR), eFFECTOR Therapeutics (EFTR), Molecular Templates (MTEM), and OncoSec Medical (ONCSQ). These companies are all part of the "medical" sector.

Innovate Biopharmaceuticals vs. Its Competitors

Innovate Biopharmaceuticals (NASDAQ:INNT) and Scopus BioPharma (NASDAQ:SCPS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

5.9% of Innovate Biopharmaceuticals shares are owned by institutional investors. 7.9% of Innovate Biopharmaceuticals shares are owned by insiders. Comparatively, 5.1% of Scopus BioPharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Innovate Biopharmaceuticals' average media sentiment score of 0.00 equaled Scopus BioPharma'saverage media sentiment score.

Company Overall Sentiment
Innovate Biopharmaceuticals Neutral
Scopus BioPharma Neutral

Company Net Margins Return on Equity Return on Assets
Innovate BiopharmaceuticalsN/A N/A -234.42%
Scopus BioPharma N/A N/A N/A

Innovate Biopharmaceuticals has a beta of -0.39, suggesting that its stock price is 139% less volatile than the S&P 500. Comparatively, Scopus BioPharma has a beta of -0.19, suggesting that its stock price is 119% less volatile than the S&P 500.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovate BiopharmaceuticalsN/AN/A-$27.05MN/AN/A
Scopus BioPharmaN/AN/A-$11.61MN/AN/A

Summary

Scopus BioPharma beats Innovate Biopharmaceuticals on 3 of the 5 factors compared between the two stocks.

Get Innovate Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for INNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INNT vs. The Competition

MetricInnovate BiopharmaceuticalsPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$8K$789.32M$5.51B$8.95B
Dividend YieldN/A4.84%5.25%4.04%
P/E Ratio-1.791.3027.9920.16
Price / SalesN/A227.08411.53174.36
Price / CashN/A23.4437.0657.97
Price / BookN/A6.138.145.62
Net Income-$27.05M-$27.58M$3.16B$248.50M

Innovate Biopharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INNT
Innovate Biopharmaceuticals
N/AN/AN/AN/A$8KN/A-1.798
SCPS
Scopus BioPharma
N/A$0.00
flat
N/AN/A$13KN/A0.009
VAXX
Vaxxinity
N/A$0.00
flat
N/A-90.3%$13KN/A0.0090Gap Down
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$9KN/A0.00120News Coverage
Options Volume
CMRA
Comera Life Sciences
N/A$0.00
flat
N/A-99.3%$6K$1.00M0.002
ARDS
Aridis Pharmaceuticals
N/A$0.00
flat
N/AN/A$5K$3.09M0.0030
STAB
Statera Biopharma
N/A$0.00
flat
N/A-83.3%$5KN/A0.0020
CLVR
Clever Leaves
N/A$0.00
flat
N/AN/A$1K$17.42M0.00560
EFTR
eFFECTOR Therapeutics
0.1686 of 5 stars
$0.00
flat
N/A-99.6%$1K$3.55M0.0010Gap Down
MTEM
Molecular Templates
N/AN/AN/AN/A$1K$23.48M0.00260
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$1KN/A0.0040

Related Companies and Tools


This page (NASDAQ:INNT) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners